US Broker Ratings

iRhythm Holdings, Inc. (IRTC) Investor Outlook: Exploring a Compelling 75% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, is garnering significant attention from investors, particularly within the medical devices industry. The San Francisco-based company, with a..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring Growth Potential and Analyst Confidence

Cardinal Health, Inc. (NYSE: CAH) is making waves in the healthcare sector with its robust market presence and promising growth potential. Currently valued at $50.72 billion, this medical distribution giant..

Prestige Consumer Healthcare (PBH) Stock Analysis: Is a 38.82% Upside Potential on the Horizon?

Prestige Consumer Healthcare Inc. (NYSE: PBH) is capturing investor attention with its compelling upside potential of nearly 39%, as indicated by analysts’ average target price of $78.50. With its diversified..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A 13.39% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH) is garnering attention from investors due to its promising potential in the healthcare sector. Specializing in diagnostic and therapeutic products for heart, cancer, and other..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Discovering a 43% Potential Upside in Healthcare Innovation

Neurocrine Biosciences, Inc. (NBIX), a healthcare entity specializing in the development and commercialization of pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders, presents an intriguing opportunity for investors. With a..

BridgeBio Pharma (BBIO) Stock Analysis: A Biotech Pioneer with 34.88% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a prominent player in the biotechnology sector, is capturing attention with its robust portfolio dedicated to treating genetic diseases. The company’s recent financial and market..

Pfizer, Inc. (PFE) Stock Analysis: Navigating Market Challenges with a 6.39% Dividend Yield

Pfizer, Inc. (NYSE: PFE), a heavyweight in the healthcare sector, is a stalwart in the drug manufacturing industry, offering a wide array of biopharmaceutical products globally. The company, headquartered in..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Unpacking the 29.84% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is drawing attention from investors, not only for its innovative strides in RNA-targeted medicines but also for the compelling 29.84% potential upside reflected in analyst..

Glaukos Corporation (GKOS) Stock Analysis: A 19% Upside Potential in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Glaukos Corporation (NYSE: GKOS) presents an intriguing opportunity. As a prominent player in the medical devices industry, Glaukos specializes in..

Revolution Medicines, Inc. (RVMD) Stock Analysis: 38.65% Potential Upside Ignites Investor Interest

Revolution Medicines, Inc. (RVMD) is capturing the attention of investors with its substantial potential upside of 38.65%, as highlighted by its average target price of $133.70 against the current market..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Unpacking a 28.67% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has been making waves in the biotech industry, particularly for investors with an eye on the burgeoning field of metabolic dysfunction-associated steatohepatitis (MASH). Headquartered in..

Penumbra, Inc. (PEN) Stock Analysis: Navigating a 10.92% Potential Upside in the Medical Devices Sector

Penumbra, Inc. (NYSE: PEN), a prominent player in the medical devices industry, has been capturing investor attention with its robust revenue growth and potential for significant upside. With a market..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 56% Potential Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT) is capturing the attention of investors with its promising potential in the biotechnology sector. Based in Miami, Florida, Summit Therapeutics is dedicated to the discovery,..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 31.71% Potential Upside in the Healthcare Sector

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, presents a compelling investment opportunity with a notable 31.71% potential upside based on current analyst ratings. As a significant..

Elanco Animal Health (ELAN) Stock Analysis: 24% Upside Potential and Robust Revenue Growth

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector specializing in specialty and generic drug manufacturing, presents a compelling opportunity for investors, underscored by its strong..

Baxter International Inc. (BAX) Stock Analysis: Evaluating a 28.95% Potential Upside Amid Market Challenges

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, stands at a crucial juncture for individual investors. With a robust market cap of $8.85 billion, the company..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 18.44% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the healthcare sector specializing in medical distribution, has recently caught the attention of investors with its promising 18.44% potential upside. With..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 25.76% Potential Upside in CNS Therapies

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its innovative focus on central nervous system (CNS) disorders. This New York-based biopharmaceutical company is capturing investor..

Doximity, Inc. (DOCS) Stock Analysis: Exploring an 85% Upside Potential in Health Information Services

Doximity, Inc. (NYSE: DOCS) is carving a niche in the healthcare sector with its digital platform tailored for medical professionals. With a market capitalization of $3.96 billion, Doximity is a..

Encompass Health Corporation (EHC) Stock Analysis: Strong Buy Ratings Signal a 33% Upside Potential

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector as a robust player within the medical care facilities industry. With a market capitalization of $10.79 billion, this Birmingham,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds